ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kameo, A Leader In Innovative Health-tech Solutions, Announces The Launch Of Their Cutting-Edge App With Artificial Intelligence Result-Detecting Technology

Los Angeles, United States - 10-17-2022 (PR Distribution™) -

Kameo's new app gives you the ability to track antigen testing while saving time and resources by using artificial intelligence to detect results automatically.

Today, Kameo announced the launch of their new mobile application which can be downloaded directly from the Apple App Store or the Google Play Store. Kameo is a female, veteran, and producer-founded company whose mission is to make it easy for productions to manage health & safety on set. Kameo’s new mobile application is designed to instantly and automatically detect the results of users’ self-administered COVID tests using Artificial Intelligence results-detecting technology. The self-administered FlowFlex module includes thorough instructions and helps you manage testing schedules, all in one place. The application can also be used on desktop for those that don’t have access to a mobile device.

On set, tracking all tests can be burdensome given that everyone may be tested in different places with different test types. With Kameo’s app, The test results page seamlessly tracks all testing history and results in one place - automatically track on-site test results in the same place as your self-administered tests, all the while having the ability to download PDFs. Additionally, productions that require cast & crew to abide by specific guidelines can ensure they are being followed with ease such as a symptom screener, vaccine requirements, and automated testing schedules. Note, the symptom screener is an optional feature and can be completed directly through the app, and easily monitored by admins. Once the crew member meets all necessary requirements, their health passport will reflect this - ensuring that the Health & Safety team doesn’t need to spend extra time cross-referencing credentials. 

Users will also be able to access The Kameo Shop to order over-the-counter COVID tests in bulk - the Kameo app has integrated with the best bulk OTC tests on the market.

The app will enhance the COVID managing experience for film and television productions, and new markets alike. In addition to the convenience that the app will provide, Kameo’s platform currently offers a suite of comprehensive tools such as bill tracking, messaging via email and text message, and more. With Kameo's AI results-detecting technology, there is no better way to track antigen testing while saving time and resources than through Kameo's new app.

About Kameo

Kameo is a female-founded company and is currently led by Alex Ostebo (Founder & President), Matt Hibberd (CEO), and Sebastian Hayto (COO). Kameo was founded as a response to the entertainment industry’s need for more systemized, streamlined health testing and management procedures in the era of COVID-19. The company is a female and veteran-founded initiative that offers flexible COVID-19 management solutions and software. 

Kameo has evolved with the industry, and now has four core offerings: on-site testing solutions, an app, a SaaS Platform, and a bulk OTC COVID test shop. One of the most recognized platforms for the Film & TV Industry, Kameo was also named Inc.’s Best in Business for Pandemic Response in 2021 and is now recognized as Hollywood’s most trusted testing partner.

As a leader in innovative health-tech solutions, Kameo offers clients a comprehensive suite of tools through their platform, including testing management and scheduling, digital vaccination tracking, customizable symptom questionnaires, and more. When it comes to providing flexible testing services, Kameo leverages over 200 nurses, a fleet of mobile labs, and a network of 30 high-throughput PCR labs for efficient onsite testing with fast results across the United States.

Kameo has successfully supported over 500 productions and administered more than 370,000 COVID-19 tests for clients including Netflix, Disney, Sony Pictures, Viacom, Legendary, HBO, and others. They have now expanded further, offering their services to businesses of various sizes and industries. For more information, please visit Kameo.co.

Contact Information

Email: madison.steiner@kameo.co | Phone Number: (424) 203-6572

Media Contacts:

Company Name: Kameo
Full Name: Madison Steiner
Phone: (424) 203-6572
Email Address: Send Email
Website: https://kameo.co

For the original news story, please visit https://www.prdistribution.com/news/kameo-a-leader-in-innovative-health-tech-solutions-announces-the-launch-of-their-cutting-edge-app-with-artificial-intelligence-result-detecting-technology/9348589.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.